These are the Financial Times Global Pharmaceutical and Biotechnology Conference 2017 and The Economist Business of Longevity 2017 Conference logos. Disclaimer: AAAS and EurekAlert! are not ...

Donald Trump’s victory in the 2024 US presidential election is sure to have an impact on the pharmaceutical industry. During a panel at the Financial Times’ 2024 Global Pharma and Biotech Summit, the ...

spoke about the issues Europe is facing with promoting pharma innovation at the Financial Times’ 2024 Global Pharma and Biotech Summit. During the conversation, which was hosted by the Financial Times ...

At the Financial Times’ Global Pharma and Biotech Summit 2024, a panel discussed ways to prepare for the high number of incoming patent expiries and how to protect key drugs. In the past few years, ...

At the Financial Times’ Global Pharma and Biotech Summit 2024, Christophe Weber, president and CEO, Takeda, discusses how trust and collaboration between the biopharma industry and stakeholders can be ...

Trailing the market is quite an effort given the collapse in bank shares, although in fairness pharma has held its own in the past year and a half. Is that a buy signal for a global sector that ...